Pulmonale Hypertonie und Rechtsherzversagen auf der Intensivstation

Por Meyer, F.J., Katus, H.A., Borst, M.M.
Publicado no Pneumologe (Berl) (2008)

The value of contrast dobutamine stress echocardiography in detecting coronary artery disease in overweight and obese patients

Por Hu, Shen-Jiang, Liu, Sheng-Xiang, Katus, HA, Luedde, Mark
Publicado em 2007

Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid

Por Jehle, J, Staudacher, I, Wiedmann, F, Schweizer, PA, Becker, R, Katus, HA, Thomas, D
Publicado em 2012

Gene therapy targets in Heart Failure: the Path to translation

Por Raake, PWJ, Tscheschner, H, Reinkober, J, Ritterhoff, J, Katus, HA, Koch, WJ, Most, P
Publicado em 2011

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation

Por Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA
Publicado em 2013-10-01

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels

Por Erbel C, Achenbach J, Akhavanpoor M, Dengler TJ, Lasitschka F, Gleissner CA, Bea F, Katus HA, Szabo G
Publicado em 2011-08-01

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels

Por Erbel, C, Achenbach, J, Akhavanpoor, M, Dengler, TJ, Lasitschka, F, Gleissner, CA, Bea, F, Katus, HA, Szabo, G
Publicado em 2011

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation

Por Kraeuter M, Helmschrott M, Erbel C, Gleissner CA, Frankenstein L, Schmack B, Ruhparwar A, Ehlermann P, Katus HA, Doesch AO
Publicado em 2013-11-01

TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation

Por Seyler, C, Duthil-Straub, E, Zitron, E, Gierten, J, Scholz, EP, Fink, RHA, Karle, CA, Becker, R, Katus, HA, Thomas, D
Publicado em 2012

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

Por Helmschrott M, Beckendorf J, Akyol C, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Ehlermann P, Bruckner T, Katus HA, Doesch AO
Publicado em 2014-09-01

Proinflammatory and prothrombotic effects on human vascular endothelial cells of Immune-cell-derived LIGHT

Por Celik S, Shankar V, Richter A, Hippe H-J, Akhavanpoor M, Bea F, Erbel C, Urban S, Blank N, Wambsganss N, Katus HA, Dengler TJ
Publicado em 2009-04-01

Rosuvastatin reduces neointima formation in a rat model of balloon injury

Por Preusch, MR, Vanakaris, A, Bea, F, Ieronimakis, N, Shimizu, T, Konstandin, M, Morris-Rosenfeld, S, Albrecht, C, Kranzhöfer, A, Katus, HA, Blessing, E, Kranzhöfer, R
Publicado em 2010

Proinflammatory and prothrombotic effects on human vascular endothelial cells of Immune-cell-derived LIGHT

Por Celik, S, Shankar, V, Richter, A, Hippe, H-J, Akhavanpoor, M, Bea, F, Erbel, C, Urban, S, Blank, N, Wambsganss, N, Katus, HA, Dengler, TJ
Publicado em 2009

A new system for quantitative determination of troponin T and myoglobin in the emergency room and in the intensive care unit

Por Waldenhofer, U, Hirsch, MM, Laggner, AN, Katus, HA, Müller-Bardorff, M, Sylvén, C, Rasmanis, G, Collinson, PO, Gerhardt, W, Hafner, G, Zerback, R, Leinberger, R
Publicado em 1998

Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced p...

Por Jehle, J, Ficker, E, Wan, X, Deschenes, I, Kisselbach, J, Wiedmann, F, Staudacher, I, Schmidt, C, Schweizer, PA, Becker, R, Katus, HA, Thomas, D
Publicado em 2013

Carvedilol targets human K(2P)3.1 (TASK1) K(+) leak channels

Por Staudacher, K, Staudacher, I, Ficker, E, Seyler, C, Gierten, J, Kisselbach, J, Rahm, A-K, Trappe, K, Schweizer, PA, Becker, R, Katus, HA, Thomas, D
Publicado em 2011

Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model

Por Weber, C, Neacsu, I, Krautz, B, Schlegel, P, Sauer, S, Raake, P, Ritterhoff, J, Jungmann, A, Remppis, AB, Stangassinger, M, Koch, WJ, Katus, HA, Müller, OJ, Most, P, Pleger, ST
Publicado em 2013